Home FDA labels 4889480e-2d59-4dbd-a808-ea7fce24f922 TriStart DHA openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
Brand name TriStart DHA
Generic name ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, D-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACIN, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE MAGNESIUM, FOLIC ACID, CYANOCOBALAMIN, IRON PENTACARBONYL, POTASSIUM IODIDE, MAGNESIUM OXIDE, DOCONEXENT, AND ICOSAPENT
Manufacturer CarWin Pharmaceutical Associates, LLC
Product type HUMAN PRESCRIPTION DRUG
SPL set ID 92ccf7d4-4527-49f0-b890-1a11b5a10086
SPL ID 4889480e-2d59-4dbd-a808-ea7fce24f922
Version 3
Effective date 2024-01-09
Source export date 2026-09-28
Source partition 7
Source file https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256 cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run 20260929T050834Z
Imported at 2026-09-29 05:48:06 Harmonized routes table Harmonized routes ORAL
Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 23 matching rows.
Type, Scope, Identifier table Type Scope Identifier Source field brand name TriStart DHA openfda.brand_name generic name ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, D-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACIN, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE MAGNESIUM, FOLIC ACID, CYANOCOBALAMIN, IRON PENTACARBONYL, POTASSIUM IODIDE, MAGNESIUM OXIDE, DOCONEXENT, AND ICOSAPENT openfda.generic_name manufacturer name CarWin Pharmaceutical Associates, LLC openfda.manufacturer_name ndc package 15370-250-30 openfda.package_ndc ndc product 15370-250 openfda.product_ndc ndc11 package 15370025030 derived:openfda.package_ndc spl id 4889480e-2d59-4dbd-a808-ea7fce24f922 id spl set id 92ccf7d4-4527-49f0-b890-1a11b5a10086 set_id unii A7E6112E4N openfda.unii unii 2679MF687A openfda.unii unii TLM2976OFR openfda.unii unii 935E97BOY8 openfda.unii unii ZAD9OKH9JC openfda.unii unii 1VZZ62R081 openfda.unii unii PQ6CK8PD0R openfda.unii unii 3A3U0GI71G openfda.unii unii M572600E5P openfda.unii unii AAN7QOV9EA openfda.unii unii P6YC3EG204 openfda.unii unii 1C4QK22F9J openfda.unii unii 68Y4CF58BV openfda.unii unii 1C6V77QF41 openfda.unii unii 6WQ62TAQ6Z openfda.unii
Boxed warning cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Boxed warning sections page 1 of 1 · 1 matching rows.
boxed warning WARNING Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Warnings cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings sections page 1 of 1 · 1 matching rows.
warnings Caution is recommended in patients taking anticonvulsant medications as folate may interfere with anticonvulsant medication, and may lower seizure threshold. Furthermore, anticonvulsant medications may interfere with folate metabolism.
Adverse reactions cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 1 matching rows.
adverse reactions ADVERSE REACTIONS Allergic sensitization has been reported following both oral and parenteral administration of folic acid. You should call your doctor for medical advice about serious adverse events. To report adverse side effects or to obtain product information, contact CarWin Pharmaceutical Associates, LLC at 1-985-288-5122
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.